|
MechanismViral thymidine kinase modulators [+1] |
|
|
Active Indication- |
|
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
TK008: Randomized Phase III Trial of Haploidentical HCT With or Without an Add Back Strategy of HSV-Tk Donor Lymphocytes in Patients With High Risk Acute Leukemia
The main objective of this randomized trial is to compare disease-free survival (DFS) in high risk leukemia patients who underwent haploidentical HCT followed by an add back strategy of HSV-Tk donor lymphocytes or standard haploidentical HCT
100 Clinical Results associated with Viral thymidine kinase
100 Translational Medicine associated with Viral thymidine kinase
0 Patents (Medical) associated with Viral thymidine kinase